格隆汇8月10日丨华检医疗(01931.HK)公告宣布，正式启动「具备下行保护机制的全球增强版以太坊 (ETH)金库」战略，并公布首批定投已以每枚3661美元均价买入5190枚ETH。 这种创新性的设计，使得Web2投资者能够在无惧市场波动的情况下，捕捉Web3链上金融红利，为传统 金融机构与数字资产之间搭建了一座稳健的桥梁。 这一战略的独特之处在于多层次"下行保护机制"。在市场波动加剧的背景下，该机制通过多元化的风险 对冲手段，确保股东、RWA持有人及潜在投资者的利益安全。同时，通过多层次"增强策略"实现以太币 (ETH)资产由"被动囤币"向"主动生息、再投资、再扩张"的质变。 该战略以两大核心框架为支撑：一是建立以太币(ETH)储备金库，采取定投式策略持续增持以太币 (ETH)，目标成为全球最大以太坊金库上市主体；二是打造以太币(ETH)创造引擎(ivd.xyz交易所)，通 过"创新药IP收购—RWA代币化—生态收益ETH化—金库储备增强"的闭环模式，实现资产的良性循环与 增值。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責 任。 一、 戰略升維之背景及商業邏輯 戰略回顧 茲提述本公司於二零二五年七月十七日發佈之自願性公告及二零二五年 七月二十日發佈之戰略進展相關自願性公告，內容有關本集團啟動「IVDNewCo Exchange」－全 球 首 個 聚 焦 醫 療 創 新 藥NewCo高科技資產的RWA交易所生態 及「IVDD」穩 定 幣 計 劃，致 力 於 以「NewCo +RWA」Web3交易所生態運作模式 徹 底 改 寫 醫 療 創 新 藥 行 業 的 資 本 效 率 與 全 球 化 進 程，解 決 醫 療 創 新 藥 行 業 長 期 面 臨 的 融 資 效 率 低、資 產 流 動 性 差 及 全 球 化 門 檻 高 等 痛 點。 – 1 – 董事會謹此宣佈，已正式將此「NewCo +RWA」Web3交易所命名為「ivd.xyz」（ivd. xyz交易所），本公司矢志構建 ...

Core Viewpoint - Huajian Medical is strategically transitioning from a traditional medical leader to a Web3 financial hub by launching the "Global Enhanced Ethereum Vault" strategy, which involves significant investments in Ethereum (ETH) as a core reserve asset [5][11]. Group 1: Strategic Initiatives - Huajian Medical has initiated a dual-track business model focusing on Ethereum (ETH) reserves and a tokenization engine for medical innovation intellectual property [5]. - The company has partnered with HashKey Group to facilitate large-scale Ethereum (ETH) transactions and explore the integration of crypto assets with real-world assets, particularly in medical innovation [6][7]. - The first purchase of 5,190 Ethereum (ETH) at a price of $3,661 per unit has resulted in a significant unrealized gain, with plans to invest an additional HKD 880 million to become a leading Ethereum reserve holder [8] [20]. Group 2: Market Context and Investment Rationale - Ethereum (ETH) is increasingly viewed as "digital oil" by Wall Street, with significant institutional interest driving its price upward, reaching $4,008.96 on August 8, 2025 [11][12]. - The demand for Ethereum (ETH) is reflected in the rapid accumulation by global companies, with 59 firms holding a total of 1.97 million ETH, representing 1.44% of the circulating supply [12]. - The investment value of Ethereum (ETH) is bolstered by its role as a leading financial infrastructure and its deflationary characteristics post-EIP-1559 upgrade, which has reduced the supply growth rate [13]. Group 3: Risk Mitigation and Value Creation - Huajian Medical has established a seven-layer down protection mechanism to safeguard shareholder interests and mitigate risks associated with Ethereum (ETH) price volatility [15]. - The company employs a three-layer enhancement engine to optimize the returns on its Ethereum vault, focusing on yield generation and capital efficiency [16]. - The strategic framework aims to create a win-win network among researchers, investors, and patients, significantly reducing the time and cost associated with bringing innovative drugs to market [23]. Group 4: Valuation Potential - Huajian Medical's valuation strategy is compared to MicroStrategy and Metaplanet, which have successfully leveraged cryptocurrency investments to enhance their market capitalization [18]. - The company's market capitalization has already surpassed HKD 12 billion, with expectations to exceed HKD 100 billion as the Ethereum vault strategy unfolds [20]. - The performance of Bitmine Immersion Technologies (BMNR), as a leading Ethereum vault holder, serves as a benchmark for Huajian Medical's potential market growth [22].

转自：新华财经 新华财经香港8月8日电（记者林迎楠） 港股上市企业华检医疗8日与香港持牌虚拟资产交易平台 HashKey Exchange正式达成战略合作，携手推进企业级数字资产与产业资本升级。 编辑：罗浩 据悉，双方将在虚拟资产配置及产业资本创新等领域展开深度协作，重点聚焦加密金库和Web3医疗资 产交易生态建设。HashKey Exchange也将进一步推动数字资产在传统产业和香港资本市场合规落地与应 用。 HashKey Exchange副总裁陈德康表示，华检医疗抢先布局数字资产，展现了以创新驱动发展的决心。 HashKey Exchange将坚持合规、安全、透明的服务标准，助力其构建加密资产金库，推动医疗资产创新 落地Web3领域。他提到，HashKey将积极融合数字与实体经济，为香港建设国际创新金融中心贡献力 量。 华检医疗首席战略官Gary Deng指出，数字经济是发展新引擎，传统产业只有主动融入，才能在新一轮 科技革命中赢得先机。通过此次合作，将增强公司抵御市场波动的能力，长期造福股东。 ...

Group 1 - BlackRock invested over $1.2 billion in ETH, significantly outpacing its $267 million investment in BTC, indicating a shift in Wall Street's capital direction towards Ethereum as "digital oil" [1] - BlackRock's Ethereum ETF (ETHA) saw its scale double from $5 billion to over $10 billion in just 10 days, reflecting a changing narrative in the financial sector [1] Group 2 - Huajian Medical announced its transformation into the first enhanced Ethereum vault company in Hong Kong, marking a strategic advancement in the market [3] - The company initiated a global enhanced Ethereum vault strategy with a multi-layered "downside protection" mechanism, including ATM financing and derivatives hedging [4] Group 3 - Huajian Medical signed a strategic agreement with HashKey Group to establish a compliant channel for large-scale ETH transactions and explore the integration of crypto assets with real-world assets [8] - The company approved the purchase of up to 5,190 ETH at an average price of HKD 28,798.21, totaling HKD 149 million, as a significant step in its vault strategy [9] Group 4 - Wall Street's investment logic has shifted, making Ethereum a necessary asset for institutional portfolios, supported by five core value pillars including its deflationary nature and yield generation [10][12] - Ethereum's annual burn rate post-EIP-1559 upgrade is between 1.2% and 2.4%, with a circulation growth rate below 0.5%, enhancing its anti-inflation characteristics [11] Group 5 - Huajian Medical's Ethereum vault strategy is closely linked to its core business of tokenizing medical innovation assets, creating a robust ecosystem [14] - The company aims to establish a Web3 exchange focused on medical intellectual property, integrating Ethereum for transaction settlements and governance [14] Group 6 - Huajian Medical's vault strategy includes an insurance mechanism to mitigate crypto asset volatility and addresses challenges in medical RWA financing [17][18] - The company aspires to become a leading platform in the medical RWA sector, enhancing financing efficiency and enabling fractional investments in high-value medical assets [19] Group 7 - The market is seeking an "Ethereum version of MicroStrategy," with Huajian Medical's systematic layout potentially positioning it for significant market capitalization growth [21] - The company's stock price surged 118% in July, with a single-day increase of 38.43% on August 6, indicating strong market interest [23] Group 8 - Huajian Medical's strategic vision includes applying for stablecoin licenses in both Hong Kong and the U.S., connecting Chinese medical assets with global capital through the Ethereum ecosystem [26] - The company aims to leverage Ethereum's properties to create a new benchmark in the Hong Kong market, integrating real-world assets with the crypto world [26]

Group 1 - BlackRock invested over $1.2 billion in ETH, significantly outpacing its $267 million investment in BTC, indicating a shift in Wall Street's capital direction from Bitcoin as "digital gold" to Ethereum as "digital oil" [1] - The rapid growth of BlackRock's Ethereum ETF (ETHA) from $5 billion to over $10 billion in just 10 days reflects changing investor sentiment towards Ethereum [1] Group 2 - Huajian Medical announced its transformation into the first enhanced Ethereum treasury company in Hong Kong, marking a strategic advancement in the market [2] - The company initiated a global enhanced Ethereum treasury strategy with a multi-layered "downside protection" mechanism and active "yield enhancement" strategies [3] Group 3 - Huajian Medical partnered with HashKey Group to establish a compliant trading channel for large-scale ETH transactions and to explore the integration of crypto assets with real-world assets (RWA) [6] - The company approved the purchase of 5,190 ETH at an average price of HKD 28,798.21, totaling HKD 149 million, as a significant step in its treasury strategy [7] Group 4 - Wall Street's consensus indicates that Ethereum is becoming a necessary asset for institutional investment, supported by five core value pillars including its deflationary nature and yield generation capabilities [8][9] - Ethereum's role as a foundational settlement asset in the DeFi ecosystem positions it as a preferred choice for RWA tokenization and stablecoin issuance [9] Group 5 - Huajian Medical's Ethereum treasury strategy is closely linked to its core business of medical RWA tokenization, aiming to create a unique ecosystem for innovative drug assets [10] - The company's ivd.xyz exchange is designed to facilitate the issuance and trading of medical RWA, integrating Ethereum as a core asset for governance and liquidity [10] Group 6 - The treasury strategy includes an "insurance mechanism" to mitigate volatility risks and a systematic investment approach to smooth costs [13][14] - Huajian Medical aims to address the challenges in innovative drug development financing through its tokenization strategy, enhancing investment efficiency [15] Group 7 - The market is recognizing the potential for Huajian Medical's treasury model to achieve significant valuation, drawing parallels to MicroStrategy's success with Bitcoin [17] - The company's stock price surged by 118% in July and 38.43% on August 6, indicating strong market interest and potential for value discovery [19] Group 8 - Huajian Medical's strategic vision includes applying for stablecoin licenses in both Hong Kong and the U.S., aiming to connect innovative drug assets with global capital through the Ethereum ecosystem [24] - The company's ambition is to leverage Ethereum's properties to create a new benchmark in the Hong Kong market, facilitating the global circulation of Chinese biomedical assets [24]

Group 1 - The core strategy of the company is to launch a "Global Enhanced Ethereum Vault" with a downward protection mechanism, positioning Ethereum (ETH) as a strategic reserve asset [2][5] - The company has entered into a strategic partnership with HashKey Group, which will provide support for large-scale ETH transactions and explore the integration of crypto assets with real-world assets (RWA) [5][10] - The company has invested 149 million HKD to purchase 5,190 ETH and plans to continue increasing its holdings through a dollar-cost averaging strategy, with an approved budget of 880 million HKD [5][10] Group 2 - The "Active Coin Generation" feature is a key highlight of the company's Ethereum Vault strategy, allowing for the tokenization of innovative drug intellectual property (RWA) and trading on the ivd.xyz exchange [8][9] - The ivd.xyz exchange is the first Web3 exchange focused on medical innovation drug RWA, combining centralized and decentralized exchange features to support cross-chain trading [8][9] - The company's downward protection mechanisms include an ATM mechanism, a priority structure, RWA price buyback commitments, and a clinical VC safety net, providing comprehensive protection for investors [9] Group 3 - The Ethereum Vault strategy opens up a potential market capitalization growth space of over 100 billion HKD, drawing parallels with MicroStrategy's Bitcoin strategy, which saw an 80-fold increase in market value [10] - The company’s current market capitalization exceeds 13 billion HKD, indicating significant growth potential compared to MicroStrategy and Metaplanet [10] - The strategy aligns with the Hong Kong Monetary Authority's Ensemble project and China's innovation drug export strategy, aiming to lower financing costs and accelerate technology transfer [11]

本文源自：金融界AI电报 华检医疗(01931.HK)发布公告，经董事会决议通过，本公司已于近日，与全球领先的数字资产金融服务 集团HashKey Group(HashKey集团)签订了全球战略合作框架协议(框架协议)，旨在通过双方的紧密合 作，加速本集团"全球增强版以太坊(ETH)金库"战略的落地实施，并为双方的全球客户提供更加高效、 安全、合规的数字资产服务。 ...

智通财经APP讯，华检医疗(01931)发布公告，经董事会决议通过，本公司已于近日，与全球领先的数字 资产金融服务集团HashKey Group(HashKey集团)签订了全球战略合作框架协议(框架协议)，旨在通过双 方的紧密合作，加速本集团"全球增强版以太坊(ETH)金库"战略的落地实施，并为双方的全球客户提供 更加高效、安全、合规的数字资产服务。 华检医疗致力于打造"全球增强版以太坊(ETH)金库"，通过以太坊(ETH)储备与创新药知识产权代币化 (RWA)的双轮驱动，提升医疗创新药研发效率、资本配置效率，并为全球投资者提供安全、高效的 Web3入口。 HashKey集团作为全球领先的数字资产金融服务集团，在合规监管框架下构建了覆盖中国 香港、新加坡、日本、百慕大等地的全球化Web3生态，其业务涵盖虚拟资产交易、数字资产管理、合 规场外交易及Web3基础设施服务等。 根据框架协议，并在遵守适用法律法规及香港联合交易所有限公司证券上市规则的前提下，此次合作将 充分利用HashKey集团的全牌照合规生态体系，为本集团提供一站式的数字资产管理服务，包括但不限 于以太坊(ETH)的大宗交易执行与成本优化、全球市场 ...

本 公 司 董 事 會（「董事會」）欣 然 宣 佈，為 推 進 本 集 團「全 球 增 強 版 以 太 坊（ETH） 金 庫」戰 略 的 快 速 落 地，經 董 事 會 決 議 批 准，本 公 司 將 可 最 多 動 用8.8億港元於 公 開 市 場 購 買 以 太 坊（ETH）作 為 儲 備 資 產。本 公 司 將 通 過 自 有 資 金 及 透 過 募 集 資 金 活 動 籌 集 的 資 金 來 加 大 購 買 額 度，將 依 上 市 規 則 適 時 作 出 進 一 步 公 告， 包 括 但 不 限 於 召 開 股 東 大 會 通 過 加 大 購 買 額 度 等。本 公 司 已 通 過 香 港 持 牌 虛 擬資產交易所HashKey Exchange完 成 首 批 以 太 坊（ETH）的 合 規 購 買，並 計 劃 通 過 定 投 式 加 倉 策 略 持 續 增 持，目 標 成 為 港 股 市 場 乃 至 全 球 以 太 坊（ETH）儲 備 規 模 領 先 的 上 市 公 司。 截 至 本 公 告 日，本 公 司 首 批 合 共 買 入5,190枚 以 太 坊（ETH），每 枚 平 均 價 格 為 28, ...